Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Hypertension
Interventions
DRUG

Telmisartan/HCTZ

DRUG

Telmisartan

Trial Locations (9)

100029

China-Japan Friendship Hospital, Beijing

100050

Beijing Tiantan Hospital, Beijing

100730

Peking Union Medical College Hospital, Beijing

200025

Ruijin Hospital, School of Medicine, Shanghai

200433

Shanghai Changhai Hospital, Shanghai

210006

No. 1 Hospital Affiliated Nanjing, Nanjing

300150

254 PLA Hospital, Tianjin

300211

Second Hospital Affiliated to Tianjin Med University, Tianjin

310003

No. 1 Hosp Affiliated to Med College, Zhejiang Province

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY